EISAI (SINGAPORE) PTE. LTD.

At Eisai Inc., human health care (hhc) is our goal. We give our first thought to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs. Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Each group functions as an end-to-end global business with discovery, development, and marketing capabilities. Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about Eisai Inc., please visit us at www.eisai.com/US. Comments and posts by users on this site are not created or controlled by Eisai Inc. and Eisai is not responsible for such content.

A leading global research and development-based pharmaceutical company headquartered in Japan, focused on neurology and oncology therapeutic areas, aiming to be a 'Medico Societal Innovator' by creating medicines and providing solutions to fulfill patients' unmet needs.

Eisai Inc. is a global healthcare company that discovers, develops, and markets innovative drugs and therapies to improve the lives of patients worldwide. Our mission is to create and deliver high-quality products that meet unmet medical needs and make a meaningful difference in people's lives.